Egnite and Pathway Labs launch FDA-cleared ECG AI pilot at Stamford Health to improve structural heart disease detection
Egnite, Pathway Labs and Stamford Health are testing whether FDA-cleared ECG artificial intelligence can improve identification and follow-up of patients with possible structural heart disease. The pilot combines automated screening with longitudinal clinical records and will measure whether flagged patients actually receive further evaluation.